Skip to main content
logo
SigmaTron International, Inc. (SGMA)
Jul 28, 2025 - SGMA was delisted (reason: acquired by Transom)
3.010
0.00 (0.00%)
Inactive · Last trade price on Jul 25, 2025

Elevation Oncology Revenue

SigmaTron International had revenue of $71.07M in the quarter ending January 31, 2025, a decrease of -25.91%. This brings the company's revenue in the last twelve months to $311.71M, down -22.27% year-over-year. In the fiscal year ending April 30, 2024, SigmaTron International had annual revenue of $373.88M, down -9.78%.

Revenue (ttm)
$311.71M
Revenue Growth
-22.27%
P/S Ratio
0.06
Revenue / Employee
$113,348
Employees
2,750
Market Cap
18.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 2024373.88M-40.55M-9.78%
Apr 30, 2023414.44M36.12M9.55%
Apr 30, 2022378.32M100.60M36.22%
Apr 30, 2021277.72M-3.32M-1.18%
Apr 30, 2020281.04M-9.51M-3.27%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SGMA News

More News